Havemeyer Place LP Invests $393,000 in Masimo Corporation $MASI

Havemeyer Place LP acquired a new position in shares of Masimo Corporation (NASDAQ:MASI) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 3,020 shares of the medical equipment provider’s stock, valued at approximately $393,000.

Other hedge funds also recently made changes to their positions in the company. Global Retirement Partners LLC bought a new stake in shares of Masimo during the 4th quarter worth $27,000. Rothschild Investment LLC lifted its holdings in shares of Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 259 shares during the last quarter. Torren Management LLC bought a new stake in shares of Masimo during the 4th quarter worth $35,000. Smartleaf Asset Management LLC lifted its holdings in shares of Masimo by 80.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 136 shares during the last quarter. Finally, Kohmann Bosshard Financial Services LLC bought a new stake in shares of Masimo during the 4th quarter worth $44,000. 85.96% of the stock is owned by institutional investors.

Masimo Price Performance

MASI opened at $179.95 on Wednesday. The stock’s 50 day simple moving average is $178.56 and its 200 day simple moving average is $159.94. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45. Masimo Corporation has a 1 year low of $125.94 and a 1 year high of $179.99. The firm has a market cap of $9.42 billion, a price-to-earnings ratio of -17.07, a PEG ratio of 1.82 and a beta of 1.11.

Analysts Set New Price Targets

A number of analysts have recently issued reports on MASI shares. BTIG Research downgraded shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a report on Wednesday, March 18th. Raymond James Financial downgraded shares of Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Piper Sandler downgraded shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective for the company. in a report on Tuesday, February 17th. Finally, Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Nine research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $180.40.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.